Literature DB >> 15472400

The initial attachment and subsequent behavior of osteoblastic cells and oral epithelial cells on titanium.

Tetsuya Goto1, Masao Yoshinari, Shigeru Kobayashi, Teruo Tanaka.   

Abstract

The interaction between implant materials and bone cells or oral epithelial (OE) cells contributes to the clinical success of dental implants. The functional activity of cells in contact with an implant is determined by its surface properties. Before cells attach, extracellular matrix (ECM) in the serum deposits on the substrate; rounded cells then attach and spread upon it. Cells form focal adhesions and polarize, then start to migrate or proliferate to form colonies. Comparison of the attachment and behavior of osteoblastic cells on titanium (Ti) and hydroxyapatite (HA) revealed that more cells attached on HA and that these spread more rapidly than on Ti. In contrast, cells did not form good stress fibers or vinculin-positive focal adhesions on HA, whereas the cells on Ti possessed well-defined and polarized stress fibers. The initial attachment of OE cells to Ti was inferior to that on polystyrene culture dish or glass, and the OE cell migration area, indicated by the deposition of LN5, was smaller on Ti than on the other materials. This review summarizes data on the attachment and behavior of osteoblastic cells and OE cells on biomaterials, which may suggest future improvements in surface properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472400

Source DB:  PubMed          Journal:  Biomed Mater Eng        ISSN: 0959-2989            Impact factor:   1.300


  8 in total

1.  Regulation of angiogenesis during osseointegration by titanium surface microstructure and energy.

Authors:  Andrew L Raines; Rene Olivares-Navarrete; Marco Wieland; David L Cochran; Zvi Schwartz; Barbara D Boyan
Journal:  Biomaterials       Date:  2010-03-30       Impact factor: 12.479

2.  Osteoblast maturation and new bone formation in response to titanium implant surface features are reduced with age.

Authors:  Rene Olivares-Navarrete; Andrew L Raines; Sharon L Hyzy; Jung Hwa Park; Daphne L Hutton; David L Cochran; Barbara D Boyan; Zvi Schwartz
Journal:  J Bone Miner Res       Date:  2012-08       Impact factor: 6.741

3.  Requirement for both micron- and submicron scale structure for synergistic responses of osteoblasts to substrate surface energy and topography.

Authors:  G Zhao; A L Raines; M Wieland; Z Schwartz; B D Boyan
Journal:  Biomaterials       Date:  2007-06       Impact factor: 12.479

4.  Comparative in vitro study regarding the biocompatibility of titanium-base composites infiltrated with hydroxyapatite or silicatitanate.

Authors:  Ioana-Carmen Brie; Olga Soritau; Noemi Dirzu; Cristian Berce; Adriana Vulpoi; Catalin Popa; Milica Todea; Simion Simon; Maria Perde-Schrepler; Piroska Virag; Otilia Barbos; Gabriela Chereches; Petru Berce; Valentin Cernea
Journal:  J Biol Eng       Date:  2014-06-19       Impact factor: 4.355

5.  Enhancement of osteoblast activity on nanostructured NiTi/hydroxyapatite coatings on additive manufactured NiTi metal implants by nanosecond pulsed laser sintering.

Authors:  Biwei Deng; Angela Bruzzaniti; Gary J Cheng
Journal:  Int J Nanomedicine       Date:  2018-11-30

6.  Comparison of the reaction of bone-derived cells to enhanced MgCl2-salt concentrations.

Authors:  Anna Burmester; Bérengère Luthringer; Regine Willumeit; Frank Feyerabend
Journal:  Biomatter       Date:  2014

7.  Effect of Fluoride-Modified Titanium Surface on Early Adhesion of Irradiated Osteoblasts.

Authors:  Jun Yuan Li; Li Wu Zheng; Li Ma; Dora Lai Wan Kwong; Lim Kwong Cheung; Edmond Ho Nang Pow
Journal:  Biomed Res Int       Date:  2015-07-22       Impact factor: 3.411

8.  Methoxy-poly(ethylene glycol) modified poly(L-lactide) enhanced cell affinity of human bone marrow stromal cells by the upregulation of 1-cadherin and delta-2-catenin.

Authors:  Xueli Mao; Zetao Chen; Junqi Ling; Jingjing Quan; Hui Peng; Yin Xiao
Journal:  Biomed Res Int       Date:  2014-04-14       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.